Our Liquid Carnitine has the added co-factors Vit
PMID: 32531956
The SELECT trial (Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity), a phase 3 study involving 17,604 adults with overweight or obesity and pre-existing CVD but no diabetes, revealed that once-weekly subcutaneous semaglutide 2.4 mg reduced the risk of major adverse cardiovascular events by 20% compared with placebo over a mean follow-up of 39.8 months, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke [48]
More recently, miR-141-3p, downregulated by lncRNA HIF1A-AS2, has been shown to promote CRC metabolic reprogramming and proliferation through FOXC1 activation, highlighting additional post-transcriptional networks under hypoxic stress [114]
It is usually well tolerated, but rare serious complications such as VPA-induced hepatotoxicity (VHT) and VPA-induced hyperammonaemic encephalopathy (VHE) may occur in some patients who receive VPA chronically [133]